BioCeramic Therapeutics attracts Sir Richard Sykes as chairman
This article was originally published in Scrip
The UK smart materials company BioCeramic Therapeutics is exploiting new findings on bioactive glasses in the regenerative tissue field, and Sir Richard Sykes has just accepted the role of chairman at the firm.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.
Copenhagen-based start-up IO Biotech has raised a hefty €127m from a group of VC investors to accelerate its IDO- and PD-L1 targeted immuno-oncology approaches to the treatment of cancer.